C. Fernández-Vidaurre

Author

Also Known As

C. Fernández-Vidaurre, Carlos Fernandez-Vidaurre, Carlos Fernández-Vidaurre, Carlos Fernández‐Vidaurre

Publications

319

Citations

H-Index

Concepts

All Affiliations

C. Fernández-Vidaurre is an author at Novartis (Switzerland) specializing in immunotherapy, scleroderma, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	93
2	Immunotherapy	1	1	93
3	Scleroderma	1	1	93
4	Dermatology	1	1	93
5	Drug Hypersensitivity	1	1	93

C. Fernández-Vidaurre

Publications

319

Citations

H-Index

Page 1

	Year	Citations
Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Alejandro Arana, Charles Wentworth, C. Fernández-Vidaurre, British Journal of Dermatology	2010	103
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom Félix Arellano, Alejandro Arana, Charles Wentworth, Journal of Allergy and Clinical Immunology Drug HypersensitivityTopical ImmunosuppressantsAtopic Dermatitis And/orAtopic DermatitisImmunotherapy	2009	93
Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma Sebastian Schneeweiß, Mike Doherty, Shao Zhu, Dermatology	2009	73
Cancer incidence in a general population of asthma patients Antonio González‐Pérez, C. Fernández-Vidaurre, Ana Gómez Rueda, Pharmacoepidemiology and Drug Safety	2005	50

Page 1